Carnegie Mellon Press Releases

Current Press Releases

Media Relations and Marketing Communications Home

Carnegie Mellon News Service Home Page

Carnegie Mellon Today

8 1/2 x 11 News

News Clips

Web News Stories

Calendar of Events

Press Release

Media Tips:
July 23, 2001

How will tissue engineering help solve medical dilemmas?

Jeffrey Hollinger, professor and director of the bone tissue engineering center at Carnegie Mellon University

Carnegie Mellon Professor Jeffrey Hollinger is using a combination of genetic protein and bone to help solve a medical mystery plaguing a nine month-old child. The child is suffering from a serious congenital malformation of the skull.

Contact: Jeffrey Hollinger (412)268-6498.

Where will tomorrow's biotechnology leaders train?

Phil Campbell, senior research scientist, Carnegie Mellon University.

Under the direction of researchers from Carnegie Mellon and other area universities, a plan is emerging to educate tomorrow's tissue engineers through a new program aimed at high school teachers and their students. The program is designed to get teachers and their students excited about new careers in biotechnology. Nationwide, approximately 153,000 people are employed in biotechnology which accounts for about $20 billion in company revenues. The average biotech company employs 31 people with annual revenues of $4.5 million.

Contact: Phil Campbell (412)268-4126.

Is the semiconductor industry staying ahead of competition?

Rob A. Rutenbar, Electrical and Computer Engineering Professor at Carnegie Mellon University.

Carnegie Mellon's new Center for Circuit Systems and Software, housed at the university's Electrical and Computer Engineering Department, will focus on improving circuit design and software used in cellular phones, video games, optical networking, broadband and analog applications. Carnegie Mellon researchers are designing circuits that will be faster, smaller and cheaper.

Contact: Rob A. Rutenbar (412)268-3334.

Will drug makers ever find a more economical process for making product?

Andy Gellman, a Chemical Engineering professor or David Sholl, assistant professor of Chemical Engineering at Carnegie Mellon.

Two Carnegie Mellon researchers are creating a new molecular template that may lead to major breakthroughs in the way drugs are manufactured for the pharmaceutical industry. The research is vital for developing more economical and purer drugs for consumers and physicians as the $145 billion pharmaceutical industry struggles to shorten time-to-market.

Contact: Andy Gellman (412)268-3848 or David Sholl (412)268-4207.

Contact: Chriss Swaney (412)268-5776


-Back to the top-

Other Carnegie Mellon News || Carnegie Mellon Home